Vicky Leamy currently serves as a Vice President Therapeutic Science and Strategy at IQVIA where she works with cross functional teams to develop therapeutic areas strategies and serves to optimize implementation of those strategies in the clinical trial space. She also serves as a lead for government, public health and pandemic preparedness work at IQVIA, including overseeing strategic partnerships with governments and NGOs and driving thought leadership through collaborations including CEPI and WHO Clinical Trials Forum among others. She has previously led the infectious diseases and vaccines delivery team at IQVIA. She held posts at i3 Research, Vical Inc., Advanced Biologics and SmithKline Beecham across clinical and preclinical development. She earned her Master’s degree from Emory University’s Rollins School of Public Health.